NPC1-like intracellular cholesterol transporter 1 (NPC1L1), also known as LDLCQ7, NPC11L1 or SLC65A2, is a multi-pass membrane protein that is encoded by the gene NPC1L1. It is widely expressed in many tissues, including liver, small intestine, kidney, lung, heart, pancreas, testis, pancreas, spleen, gall bladder, muscle, brain, and stomach. The structure of NPC1L1 is characterized by a conserved N-terminal Niemann-Pick C1 (NPC1) domain and a putative sterol-sensing domain (SSD) which includes a YQRL motif. There are four different isoforms caused by alternative splicing have been found for this gene.
Basic Information of NPC1L1 | |
Protein Name | NPC1-like intracellular cholesterol transporter 1 |
Gene Name | NPC1L1 |
Aliases | Niemann-Pick C1-like protein 1 |
Organism | Homo sapiens (Human) |
UniProt ID | Q9UHC9 |
TransmNPC1L1rane Times | 13 |
Length (aa) | 1359 |
Sequence | MAEAGLRGWLLWALLLRLAQSEPYTTIHQPGYCAFYDECGKNPELSGSLMTLSNVSCLSNTPARKITGDHLILLQKICPRLYTGPNTQACCSAKQLVSLEASLSITKALLTRCPACSDNFVNLHCHNTCSPNQSLFINVTRVAQLGAGQLPAVVAYEAFYQHSFAEQSYDSCSRVRVPAAATLAVGTMCGVYGSALCNAQRWLNFQGDTGNGLAPLDITFHLLEPGQAVGSGIQPLNEGVARCNESQGDDVATCSCQDCAASCPAIARPQALDSTFYLGQMPGSLVLIIILCSVFAVVTILLVGFRVAPARDKSKMVDPKKGTSLSDKLSFSTHTLLGQFFQGWGTWVASWPLTILVLSVIPVVALAAGLVFTELTTDPVELWSAPNSQARSEKAFHDQHFGPFFRTNQVILTAPNRSSYRYDSLLLGPKNFSGILDLDLLLELLELQERLRHLQVWSPEAQRNISLQDICYAPLNPDNTSLYDCCINSLLQYFQNNRTLLLLTANQTLMGQTSQVDWKDHFLYCANAPLTFKDGTALALSCMADYGAPVFPFLAIGGYKGKDYSEAEALIMTFSLNNYPAGDPRLAQAKLWEEAFLEEMRAFQRRMAGMFQVTFMAERSLEDEINRTTAEDLPIFATSYIVIFLYISLALGSYSSWSRVMVDSKATLGLGGVAVVLGAVMAAMGFFSYLGIRSSLVILQVVPFLVLSVGADNIFIFVLEYQRLPRRPGEPREVHIGRALGRVAPSMLLCSLSEAICFFLGALTPMPAVRTFALTSGLAVILDFLLQMSAFVALLSLDSKRQEASRLDVCCCVKPQELPPPGQGEGLLLGFFQKAYAPFLLHWITRGVVLLLFLALFGVSLYSMCHISVGLDQELALPKDSYLLDYFLFLNRYFEVGAPVYFVTTLGYNFSSEAGMNAICSSAGCNNFSFTQKIQYATEFPEQSYLAIPASSWVDDFIDWLTPSSCCRLYISGPNKDKFCPSTVNSLNCLKNCMSITMGSVRPSVEQFHKYLPWFLNDRPNIKCPKGGLAAYSTSVNLTSDGQVLDTVAILSPRLEYSGTISAHCNLYLLDSTSRFMAYHKPLKNSQDYTEALRAARELAANITADLRKVPGTDPAFEVFPYTITNVFYEQYLTILPEGLFMLSLCLVPTFAVSCLLLGLDLRSGLLNLLSIVMILVDTVGFMALWGISYNAVSLINLVSAVGMSVEFVSHITRSFAISTKPTWLERAKEATISMGSAVFAGVAMTNLPGILVLGLAKAQLIQIFFFRLNLLITLLGLLHGLVFLPVILSYVGPDVNPALALEQKRAEEAVAAVMVASCPNHPSRVSTADNIYVNHSFEGSIKGAGAISNFLPNNGRQF |
As its name suggests, NPC1L1 mainly plays a critical role in the absorption of intestinal cholesterol by taking up free cholesterol into cells through vesicular endocytosis, maintaining cholesterol homeostasis. What' more, NPC1L1 participates in the transport of multiple lipids and the regulation of lipid metabolism to keep their homeostasis. NPC1L1 deficiency may lead to multiple lipid transport defects. NPC1L1 mutations are thus associated with low-density lipoprotein cholesterol (LDL-C) levels and plasma total cholesterol and coronary heart disease (CHD) risk. It has been reported that NPC1L1 is the direct target of ezetimibe, which can inhibit the absorption of alpha-tocopherol and intestinal cholesterol. NPC1L1 participates at a late step in viral entry via a virion cholesterol-dependent mechanism, suggesting its potential as an antiviral target.
Fig.1 Crystal structure of NPC1L1 NTD. (Kwon, 2011)
This article demonstrates that knockout of NPC1L1 gene protects against colitis-associated tumorigenesis. NPC1L1 knockout can reduce plasma lipid, especially cholesterol, to decrease inflammation.
This article indicates that hepatic NPC1L1 may have different properties of repressing gluconeogenesis via inhibition of FoxO1 pathways by overexpressing NPC1L1 in the livers of lean wild-type mice, db/db mice, and diet-induced obesity mice.
This article demonstrates that NPC1L1 is a key regulator of a modulator of warfarin therapy and intestinal vitamin K absorption.
This article gives a detailed analysis of NPC1L1 mutations in an exceptional responder to ezetimibe, showing that NPC1L1 mutations can affect the uptake of cholesterol in the presence of ezetimibe.
This article demonstrates that uptake of cholesterol by NPC1L1 does not dependent on endocytosis; additionally, ezetimibe interferes with adsorption activity of NPC1L1's cholesterol but not block internalization of NPC1L1 in RH7777 cells.
In order to provide high-quality membrane protein preparation service, we have developed a versatile Magic™ membrane protein production platform. Our experienced scientists will do their best to help you find a perfect match in your required formats. Aided by our versatile Magic™ anti-membrane protein antibody discovery platform, we also provide customized anti-NPC1L1 antibody development services.
Creative Biolabs is dedicated to providing first-class membrane protein production service using a variety of strategies. Based on our leading-edge platform, we have successfully produced, purified, stabilized and characterized many challenging membrane protein targets for global customers. If you are interested in the service we can provide, please feel free to contact us for more information.
Reference
All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.